187 related articles for article (PubMed ID: 9288174)
1. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex.
Grauert M; Bechtel WD; Ensinger HA; Merz H; Carter AJ
J Med Chem; 1997 Aug; 40(18):2922-30. PubMed ID: 9288174
[TBL] [Abstract][Full Text] [Related]
2. BIII 277 CL is a potent and specific ion-channel blocker of the NMDA receptor-channel complex.
Carter AJ; Bechtel WD; Grauert M; Harrison P; Merz H; Stransky W
J Pharmacol Exp Ther; 1995 Dec; 275(3):1382-9. PubMed ID: 8531106
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.
Grauert M; Rho JM; Subramaniam S; Rogawski MA
J Pharmacol Exp Ther; 1998 May; 285(2):767-76. PubMed ID: 9580625
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
[TBL] [Abstract][Full Text] [Related]
5. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.
Hood WF; Gray NM; Dappen MS; Watson GB; Compton RP; Cordi AA; Lanthorn TH; Monahan JB
J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886
[TBL] [Abstract][Full Text] [Related]
6. Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination.
Carter AJ
J Pharmacol Exp Ther; 1994 May; 269(2):573-80. PubMed ID: 7514220
[TBL] [Abstract][Full Text] [Related]
7. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
8. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Lü Y; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1996 Aug; 39(17):3248-55. PubMed ID: 8765507
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke.
Grauert M; Bechtel WD; Weiser T; Stransky W; Nar H; Carter AJ
J Med Chem; 2002 Aug; 45(17):3755-64. PubMed ID: 12166948
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of pentacycloundecylamines at the N-methyl-d-aspartate receptor.
Geldenhuys WJ; Malan SF; Bloomquist JR; Van der Schyf CJ
Bioorg Med Chem; 2007 Feb; 15(3):1525-32. PubMed ID: 17157509
[TBL] [Abstract][Full Text] [Related]
12. Polyamines and the NMDA receptor: modifying intrinsic activities with aromatic substituents.
Berger ML; Bitar AY; Waitner MJ; Rebernik P; O'Sullivan MC
Bioorg Med Chem Lett; 2006 Jun; 16(11):2837-41. PubMed ID: 16563762
[TBL] [Abstract][Full Text] [Related]
13. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.
Shukla VK; Prasad JA; Lemaire S
J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375
[TBL] [Abstract][Full Text] [Related]
14. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.
Pasquinucci L; Iadanza M; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Parenti C; De Luca L; Ronsisvalle G
Pharmazie; 2007 Nov; 62(11):813-24. PubMed ID: 18065096
[TBL] [Abstract][Full Text] [Related]
15. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex.
Berger ML; Rebernik P
J Pharmacol Exp Ther; 1999 Jun; 289(3):1584-91. PubMed ID: 10336556
[TBL] [Abstract][Full Text] [Related]
16. Lead inhibits the rat N-methyl-d-aspartate receptor channel by binding to a site distinct from the zinc allosteric site.
Lasley SM; Gilbert ME
Toxicol Appl Pharmacol; 1999 Sep; 159(3):224-33. PubMed ID: 10486309
[TBL] [Abstract][Full Text] [Related]
17. (E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.
Balsamini C; Bedini A; Diamantini G; Spadoni G; Tontini A; Tarzia G; Di Fabio R; Feriani A; Reggiani A; Tedesco G; Valigi R
J Med Chem; 1998 Mar; 41(6):808-20. PubMed ID: 9526557
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphan.
Zhou Q; Duan WH; Cohen DJ; Bidlack JM; Wentland MP
Yao Xue Xue Bao; 2003 Oct; 38(10):748-53. PubMed ID: 14730897
[TBL] [Abstract][Full Text] [Related]
19. Endobain E, a brain endogenous factor, is present and modulates NMDA receptor in ischemic conditions.
Reinés A; Zárate S; Carmona C; Negri G; Peña C; Rodríguez de Lores Arnaiz G
Life Sci; 2005 Dec; 78(3):245-52. PubMed ID: 16107263
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure/NMDA receptor affinity relationships of 1-substituted tetrahydro-3-benzazepines.
Krull O; Wünsch B
Bioorg Med Chem; 2004 Mar; 12(6):1439-51. PubMed ID: 15018917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
